Literature DB >> 11517415

Challenges for clinical trials on progressive multifocal leukoencephalopathy.

D B Clifford1.   

Abstract

Mesh：

Substances：

Year:  2001        PMID： 11517415     DOI： 10.1080/13550280152537229

Source DB:  PubMed          Journal:  J Neurovirol        ISSN： 1355-0284            Impact factor:   2.643


× No keyword cloud information.
  5 in total

1.  HAART improves prognosis in HIV-associated progressive multifocal leukoencephalopathy.

Authors:  D B Clifford; C Yiannoutsos; M Glicksman; D M Simpson; E J Singer; P J Piliero; C M Marra; G S Francis; J C McArthur; K L Tyler; A C Tselis; N E Hyslop
Journal:  Neurology       Date:  1999-02       Impact factor: 9.910

2.  Failure of cytarabine in progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. AIDS Clinical Trials Group 243 Team.

Authors:  C D Hall; U Dafni; D Simpson; D Clifford; P E Wetherill; B Cohen; J McArthur; H Hollander; C Yainnoutsos; E Major; L Millar; J Timpone
Journal:  N Engl J Med       Date:  1998-05-07       Impact factor: 91.245

3.  Relation of JC virus DNA in the cerebrospinal fluid to survival in acquired immunodeficiency syndrome patients with biopsy-proven progressive multifocal leukoencephalopathy.

Authors:  C T Yiannoutsos; E O Major; B Curfman; P N Jensen; M Gravell; J Hou; D B Clifford; C D Hall
Journal:  Ann Neurol       Date:  1999-06       Impact factor: 10.422

4.  Cidofovir added to HAART improves virological and clinical outcome in AIDS-associated progressive multifocal leukoencephalopathy.

Authors:  A De Luca; M L Giancola; A Ammassari; S Grisetti; A Cingolani; M G Paglia; A Govoni; R Murri; L Testa; A D Monforte; A Antinori
Journal:  AIDS       Date:  2000-09-29       Impact factor: 4.177

5.  Progressive multifocal leukoencephalopathy in patients with HIV infection.

Authors:  J R Berger; L Pall; D Lanska; M Whiteman
Journal:  J Neurovirol       Date:  1998-02       Impact factor: 2.643
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.